-
-
Ultrathin bronchoscopy with radial endobronchial ultrasound and rapid on-site evaluation for the diagnosis of peripheral pulmonary lesions: a multicentre randomized controlled factorial trial. Chest (IF 9.5) Pub Date : 2025-05-24
Erik Vakil,Marc Fortin,Anne V Gonzalez,Laïla Samy,Alex C Chee,Elaine Dumoulin,Marie Dvorakova,Christopher A Hergott,Moosa Khalil,Noël Lampron,Paul MacEachern,Simon Martel,Benjamin Shieh,Mathieu Simon,Thibaud Soumagne,Tatjana Terzic,Alain TremblayBACKGROUND The routine use of computed tomography and lung cancer screening has increased the incidence of peripheral pulmonary lesions (PPLs). Sampling may be needed for some nodules. Many new technologies are available to improve the diagnostic performance of bronchoscopy for the sampling of PPLs, but few comparative trials exist. The objective of this study was to compare the diagnostic performance
-
Pulmonary Rehabilitation Referral Practice Patterns across Lung Transplant Centers in the US: A Multi-Center Survey-Based Study. Chest (IF 9.5) Pub Date : 2025-05-24
Juan D Deleija,Sadia Z Shah,Jamie Felzer,Chris Garvey,Thomas W DeCato,Kelly Pennington,Sameep Sehgal,Cassie Kennedy,Anupam KumarBACKGROUND Functional status and frailty are important considerations in lung transplant (LT) candidacy due to the potential impact on post LT outcomes. Once listed, waitlist duration can be unpredictable, and preservation of functional capacity is thus critical to prevent deterioration in conditioning. Pulmonary rehabilitation (PR) has been deemed to be a cornerstone of management of chronic lung
-
To Make a Self: Exploring and Supporting Professional Identity Formation and Resilience of Intensivists through Humanities. Chest (IF 9.5) Pub Date : 2025-05-23
Briseida Mema,Andrew Helmers,Catherine Proulx,Laura E NavneBACKGROUND Becoming a clinician requires not only the accumulation of medical knowledge but also the development of a professional identity. The humanities may illuminate how professional and personal experiences shape identity, support meaning-making, and foster resilience through reflection and creative expression. RESEARCH QUESTION What transformative experiences disrupt the professional identity
-
HOW I DO IT Selecting An Inhaled Delivery System in COPD. Chest (IF 9.5) Pub Date : 2025-05-23
Donald A Mahler,David M G HalpinChallenges facing health care professionals (HCPs) in selecting an inhaled medication-delivery system for patients with chronic obstructive pulmonary disease (COPD) include: 1. numerous maintenance medications and combinations; 2. at least 22 different handheld inhaler devices; 3. management recommendations focusing mainly on classes of medications; 4. lack of knowledge about available medications/combinations
-
Tezepelumab in patients with eosinophilic granulomatosis with polyangiitis (EGPA) following suboptimal response to anti-IL5/5R therapy. Chest (IF 9.5) Pub Date : 2025-05-21
Alexandra M Nanzer,Jessica Gates,Faizan Haris,Grainne d'Ancona,Claire Hopkins,Michelle Fernando,Tevfik F Ismail,Jaideep Dhariwal,David J Jackson -
Sputum Cellularity and MRI Ventilation Defects in Severe Asthma. Chest (IF 9.5) Pub Date : 2025-05-20
Hana Serajeddini,Ashutosh Thakar,Melanie Kjarsgaard,Chynna Huang,Nandhitha Ragunayakam,Ekamdeep Sandhu,Carmen Venegas Garrido,Yonni Friedlander,Norm Konyer,Kayla Zhang,Nadia Suray Tan,Katherine Radford,Manali Mukherjee,Parameswaran Nair,Sarah SvenningsenBACKGROUND Airway inflammation is a hallmark feature of asthma characterized by elevated eosinophils and/or neutrophils. Eosinophils in sputum can contribute to ventilation defects. The functional consequence of other types of cellularity on ventilation is unknown. RESEARCH QUESTION What is the effect of different sputum cellular phenotypes on abnormal ventilation evaluated by 129Xe magnetic resonance
-
Diagnosing pulmonary embolism during pregnancy: A narrative review. Chest (IF 9.5) Pub Date : 2025-05-20
Meriem Hammache,Camille Simard,Sandrine Hamel,Suzie Ouellet,Gisèle Jolicoeur,Karen Wou,Kate Sellen,Ramy El-Jalbout,Jayson Potts,Ghada Bourjeily,Maral Koolian,Vicky Tagalakis,Leslie Skeith,Grégoire Le Gal,Isabelle MalhaméTOPIC IMPORTANCE Pulmonary embolism (PE) is one of the leading causes of pregnancy-related deaths in high-income countries. Maternal mortality from PE has been attributed to delayed recognition and investigations. The diagnosis of PE may be challenging, as its early signs and symptoms may overlap with physiologic changes of pregnancy. As such, promptly ruling out suspected PE using diagnostic testing
-
Prediction pathway for severe asthma exacerbations: a Bayesian Network analysis. Chest (IF 9.5) Pub Date : 2025-05-19
Chandra Prakash Yadav,Atlanta Chakraborty,David B Price,Laura Huey Mien Lim,Yah Ru Juang,Richard Beasley,Mohsen Sadatsafavi,Christer Janson,Mariko Koh Siyue,Eileen Wang,Michael E Wechsler,David J Jackson,John Busby,Liam G Heaney,Paul E Pfeffer,Bassam Mahboub,Diahn-Warng Perng Steve,Borja G Cosio,Luis Perez-de-Llano,Riyad Al-Lehebi,Désirée Larenas-Linnemann,Mona S Al-Ahmad,Chin Kook Rhee,Takashi IwanagaBACKGROUND Accurate risk prediction of exacerbations is pivotal in severe asthma management. Multiple risk factors are at play, but the pathway of risk prediction remains unclear. RESEARCH QUESTION How do the interplays of clinically relevant predictors lead to severe exacerbations in patients with severe asthma? STUDY DESIGN AND METHODS Severe asthma patients (N=6814, ≥18 years), biologic naïve, were
-
How I do it: Best practices for right heart catheterization in the diagnosis of pulmonary hypertension. Chest (IF 9.5) Pub Date : 2025-05-16
Yuri Matusov,Nicholas A Kolaitis,Dael Geft,Jacqueline DesJardin,Christopher Barnett,Antoine Hage,Teresa De Marco,Michael I LewisRight heart catheterization (RHC) is the gold standard for the diagnosis of pulmonary hypertension (PH). There are variations in practice and several pitfalls introducing errors in diagnosis that can significantly impact treatment. Errors in assessing the correct pulmonary artery wedge pressure (PAWP) can significantly affect accurate classification of patients with pulmonary hypertension, and lead
-
Association between a Recalled Positive Airway Pressure (PAP) Device and Obstructive Lung Disease: A Province-Based Study. Chest (IF 9.5) Pub Date : 2025-05-16
Tetyana Kendzerska,Robert Talarico,Marcus Povitz,Kenneth Blades,Constance Mackenzie,Andrea S Gershon,Najib T Ayas,Marta Kaminska,Mark Fenton,Kerry A McBrien,Steven Hawken,Diana Ratycz,Robert L Owens,Sachin R PendharkarBACKGROUND Limited real-world data exist on the health impacts of the Philips Respironics recall for positive airway pressure (PAP) devices. RESEARCH QUESTION What is the relationship between PAP device manufacturer and obstructive lung disease (OLD) development and progression? STUDY DESIGN AND METHODS We conducted a retrospective longitudinal study using Ontario health administrative databases (Canada)
-
Discriminative Accuracy of the Simplified Spirometry for Identifying Spirometry-defined Chronic Obstructive Pulmonary Disease in Community. Chest (IF 9.5) Pub Date : 2025-05-16
Fan Wu,Gaoying Tang,Zhishan Deng,Qi Wan,Kunning Zhou,Heshen Tian,Binwei Hao,Cuiqiong Dai,Zihui Wang,Siqi Zou,Xiulin Liao,Si Huang,Qiaorui Zhou,Yuyan Hou,Jincong Gan,Huixian Lin,Xianliang Zeng,Lifei Lu,Suyin Huang,Changli Yang,Shengtang Chen,Yongqing Huang,Shuqing Yu,Yumin Zhou,Pixin RanBACKGROUND Low spirometry testing rate for screening of chronic obstructive pulmonary disease (COPD) is partly attributed to complex procedures, stringent quality control requirements, and long examination times. Simplifying the spirometry protocol may increase the feasibility of COPD screening in community settings. RESEARCH QUESTION Does the simplified spirometry protocol have high diagnostic accuracy
-
Health and Utilization Burden of Obstructive Sleep Apnea among U.S. Active-Duty Military Personnel. Chest (IF 9.5) Pub Date : 2025-05-12
Emerson M Wickwire,Vincent F Capaldi,Jeph Herrin,Benoit Stryckman,Connie Thomas,Scott G Williams,J Kent Werner,Wendy Funk,Thomas Nassif,Jennifer S AlbrechtBACKGROUND Despite the significant health and economic burden associated with obstructive sleep apnea (OSA) among civilians, little is known about this burden among active-duty military personnel. RESEARCH QUESTION What is the health and utilization burden of OSA among active-duty service members in the United States? STUDY DESIGN AND METHODS Data were derived from the Military Data Repository (2016-2021)
-
Proteomic analysis of nasopharyngeal aspirate biomarkers for prematurity-related bronchopulmonary dysplasia. Chest (IF 9.5) Pub Date : 2025-05-12
Fernando Garrido-Muñoz,Alejandro Fernández-Vega,Rebeca Gregorio-Hernández,Marta Padín-Fontán,Mónica de Las Heras-Martín,Marta Teresa-Palacio,Paula Alonso-Quintela,Alberto Trujillo-Fagundo,Alba Pérez-Pérez,Marcelino Pumarada-Prieto,Jon Montero-Gato,Victoria Aldecoa-Bilbao,Ignacio Oulengo-Erroz,Mario Sánchez-Fernández,Almudena Alonso-OjembarrenaBACKGROUND The high incidence of bronchopulmonary dysplasia (BPD) continues to be a problem among extremely low-gestational-age neonates (ELGANs). Recent improvements in next-generation proteomics have provided opportunities to obtain new perspectives on the early detection of BPD. In this study, our main objectives were to study the proteomes of patients by collecting nasopharyngeal aspirate (NPA)
-
Lung Function Decline and Airflow Limitation Risk in Preserved Ratio Impaired Spirometry (PRISm) Subtypes by Smoking Status. Chest (IF 9.5) Pub Date : 2025-05-10
Cuiqiong Dai,Fan Wu,Jia Tian,Jiangyu Cui,Zhishan Deng,Heshen Tian,Peiyu Huang,Huajing Yang,Youlan Zheng,Zihui Wang,Shan Xiao,Xiang Wen,Lifei Lu,Ningning Zhao,Changli Yang,Shuqing Yu,Shengming Liu,Dali Wang,Xiaoping Wang,Jiachun Lu,Nanshan Zhong,Yumin Zhou,Pixin RanBACKGROUND PRISm is regarded as a COPD precursor, but whether this varies by smoking status remains unclear. RESEARCH QUESTION Are annual lung function decline and the risk of developing airflow limitation different among PRISm subtypes by smoking status? STUDY DESIGN AND METHODS 2850 participants from a 15-year population-based prospective cohort were included in this analysis. Participants were categorized
-
Evaluating the Non-Malignancy Rate in the National Lung Screening Trial: Addressing Surgical Misclassification. Chest (IF 9.5) Pub Date : 2025-05-09
Christopher R Caruso,Roger Y Kim,Katharine A Rendle,Anil Vachani -
The Impact of Healthcare Disparities on Lung Cancer Screening and Treatment. Chest (IF 9.5) Pub Date : 2025-05-09
Brett Bade,Saadia A Faiz,Miranda Tan,Aaron D Baugh,Mark Lavercombe,Ajay SheshadriFrom screening to treatment, the continuum of lung cancer care suffers from unequal access and delivery, with more vulnerable patients less able to receive high-quality care. Despite great advances in lung cancer care (e.g., screening and nodule programs to identify early-stage disease and immune-mediated and targeted therapies for advanced-stage disease), disparities persist both in the United States
-
Pregnancy Outcomes in 53 Female Lung Transplant Recipients. Chest (IF 9.5) Pub Date : 2025-05-09
Frank G Lee,Lisa A Coscia,Serban Constantinescu,Michael J MoritzBACKGROUND Limited data exists to inform and appropriately counsel female lung transplant (LuT) recipients regarding post-transplant pregnancy. QUESTION What are the modifiable factors that impact pregnancy outcomes in female LuT recipients? STUDY DESIGN AND METHODS Retrospective observational analysis was performed on female LuT recipients who reported post-transplant pregnancies to the Transplant
-
Practice Patterns and Patient Travel Distances for Lung Cancer Surgery in the United States: Analyses of the Veterans Health Administration and the National Cancer Database. Chest (IF 9.5) Pub Date : 2025-05-08
Steven Tohmasi,Daniel B Eaton,Nikki E Rossetti,Brendan T Heiden,Theodore S Thomas,Martin W Schoen,Ana A Baumann,Su-Hsin Chang,Yan Yan,Mayank R Patel,Whitney S Brandt,Bryan F Meyers,Benjamin D Kozower,Varun Puri -
Defining Interstitial Lung Disease Education in Pulmonary Fellowship: A Mixed Methods Study: Defining ILD Education in Pulmonary Fellowship. Chest (IF 9.5) Pub Date : 2025-05-07
Samantha Irene King,Anna Neumeier,Bridget Graney,Maryl Kreider,Ryan Peterson,Tristan HuieBACKGROUND Patients with interstitial lung disease (ILD) often receive care from general pulmonologists, as geographic and financial barriers limit access to specialized care centers. However, graduating pulmonary fellows lack confidence in managing patients with ILD. Refining ILD education in pulmonary fellowship could address this gap, but what trainees must learn is not currently defined. RESEARCH
-
Lung Cancer Screening Adherence in Centralized versus Decentralized Screening Programs A Meta-Analysis of U.S. Cohort Studies Among Individuals with Negative Baseline Results. Chest (IF 9.5) Pub Date : 2025-05-07
Elochukwu Ezenwankwo,Camden Jones,Duong Thuy Nguyen,Jan M EberthBACKGROUND With growing interest in a centralized approach to lung cancer screening (LCS), pooling current evidence to estimate its impact on annual adherence is essential for aligning practice with guideline recommendations. RESEARCH QUESTION Is participation in a centralized screening program associated with higher adherence rates compared to decentralized programs among individuals with negative
-
Trends in Medicare Spending on Drugs for Pulmonary Arterial Hypertension, 2012-2022. Chest (IF 9.5) Pub Date : 2025-05-05
Jenny A Shih,Charlie Lee,William B Feldman -
Not All Tele-Pulmonary Rehabilitation Models for Chronic Respiratory Disease Are Created Equal. Chest (IF 9.5) Pub Date : 2025-05-01
Marilyn L Moy,Surya P Bhatt,Richard Casaburi,Chris Garvey,Linda Nici -
Corrigendum to: Moores LK, Tritschler T, Brosnahan S, et al. Chest. 2022;162(1):213-225. Chest (IF 9.5) Pub Date : 2025-05-01
-
"The Kafka's Disease": Tracheal TB and the Role of Ultrasound. Chest (IF 9.5) Pub Date : 2025-05-01
Pietro Impellizzeri,Guido Levi,Alessia Di Mari,Santi Nolasco,Claudia Crimi,Carlo Vancheri,Gian Pietro Marchetti -
Rebuttal From Drs Oldham and Cottin. Chest (IF 9.5) Pub Date : 2025-05-01
Justin M Oldham,Vincent Cottin -
A 7-Year-Old Girl With Multiple Pulmonary Nodules. Chest (IF 9.5) Pub Date : 2025-05-01
Jie Jiang,Yamin Rao,Chenglei Liu,Shih-Jen Chang,Yajing Qiu,Xiaoxi LinA 7-year-old girl was referred to our vascular anomaly center for further evaluation of multiple lung nodules. These nodules were incidentally detected on a CT scan during hospitalization for treatment of mycoplasma pneumonia at another hospital. The biopsy results suggested the possibility of vascular tumors. Physical examination revealed clear breath sounds without rales. Furthermore, no skin lesions
-
POINT: Should the Progressive Pulmonary Fibrosis Clinical Practice Guideline Be Adopted for Clinical Practice? Yes. Chest (IF 9.5) Pub Date : 2025-05-01
Daniel-Costin Marinescu,Christopher J Ryerson -
Disease Beyond the Lungs: Optimal Care of Multi-Organ Disease After Lung Transplantation. Chest (IF 9.5) Pub Date : 2025-05-01
A Whitney Brown,Erin E Tallarico,Virginia Steen -
Extra-ICU Unsurvivability: Impermissible to Unilaterally Withdraw Extracorporeal Membrane Oxygenation. Chest (IF 9.5) Pub Date : 2025-05-01
Thaddeus Mason Pope -
Lipoid Pneumonia Following Chronic Aspiration of Cannabis Oil Used for the Treatment of Seizures. Chest (IF 9.5) Pub Date : 2025-05-01
Nacera Hanzal,Gunjan Sanjay Mhapankar,Erick Sell,Joseph de Nanassy,Dhenuka RadhakrishnanA 4-year-old girl with ring chromosome 14, epilepsy, global developmental delay, and failure to thrive presented for a preoperative assessment for gastrostomy tube (G-tube) insertion and was incidentally found to be hypoxemic, with saturations of 81% in room air. There was no history of fever or upper respiratory tract infection symptoms; however, her parents described a progressive history of choking
-
Differences in Expert Opinion on Selection of Initial Biologics and Biologic Switching in Severe Asthma. Chest (IF 9.5) Pub Date : 2025-05-01
İnsu Yılmaz,Murat Türk -
APCCMPD and CHEST Medical Educator Scholar Fellowship: A Novel Mechanism to Build Diverse Medical Educators. Chest (IF 9.5) Pub Date : 2025-05-01
Mary Elizabeth Kreider,Kristin M Burkart,Joyce Reitzner,James A Frank,Jack Buckley,Doreen Addrizzo-Harris -
Rebuttal From Drs Marinescu and Ryerson. Chest (IF 9.5) Pub Date : 2025-05-01
Daniel-Costin Marinescu,Christopher J Ryerson -
Corrigendum to: Chen H, Deng ZX, Sun J, et al. Chest. 2023;163(1):100-114. Chest (IF 9.5) Pub Date : 2025-05-01
-
-
COUNTERPOINT: Should the Progressive Pulmonary Fibrosis Clinical Practice Guideline Be Adopted for Clinical Practice? No. Chest (IF 9.5) Pub Date : 2025-05-01
Justin M Oldham,Vincent Cottin -
Is a "Fine Tuning" of the Flow Rate During High Flow Oxygen Therapy Clinically Relevant?: The Optimal Setting of High Flow Nasal Cannula Should Be Explored Further. Chest (IF 9.5) Pub Date : 2025-05-01
Alessandro Galazzi,Giacomo Grasselli -
History and Progress: New Indices for Assessing Progression From Contingency to Crisis Care Conditions. Chest (IF 9.5) Pub Date : 2025-05-01
Kelly M Griffin -
Noninvasive BP Measurements, Regardless of Position, Are Not a Substitute for Intraarterial BP Monitoring in the Hemodynamically Unstable. Chest (IF 9.5) Pub Date : 2025-05-01
Andrew Alberter,Daniel J Haase -
Increasing Sarcoidosis Mortality Rates in United States Veterans: Who Are More Affected and Why? Chest (IF 9.5) Pub Date : 2025-05-01
Marios Rossides -
Epicardial Adipose Tissue and Pulmonary Arterial Hypertension. Chest (IF 9.5) Pub Date : 2025-05-01
Farbod N Rahaghi -
Homebound: Neighborhood Deprivation and Lung Nodule Follow-Up. Chest (IF 9.5) Pub Date : 2025-05-01
Lawrence N Benjamin,Christopher G Slatore -
A Prospective, Multicenter Evaluation of Safety and Diagnostic Outcomes with Robotic-Assisted Bronchoscopy: Results of the Transbronchial Biopsy Assisted by Robot Guidance in the Evaluation of Tumors of the Lung (TARGET) Trial. Chest (IF 9.5) Pub Date : 2025-04-27
Septimiu Murgu,Alexander C Chen,Christopher R Gilbert,Daniel H Sterman,Damaris Pederson,Samaan Rafeq,Balaji Laxmanan,Michael L Schwiers,Jaime Connelly,Heather L Benz,Kazuhiro Yasufuku,Gerard A Silvestri,BACKGROUND It remains challenging to safely and reliably biopsy peripheral pulmonary lesions (PPLs). Robotic-assisted bronchoscopy (RAB) is gaining adoption for navigation to PPLs. However, evidence from large studies remains limited. RESEARCH QUESTION What is the clinical safety, navigational success, and diagnostic yield of RAB for biopsy of PPLs in a broad range of patients in a real-world setting
-
Postoperative Lung Transplant Considerations in the Older Recipient Chest (IF 9.5) Pub Date : 2025-04-22
Sandrine Hanna MD, Kristi Beermann PharmD BCPS BCTXP, Deborah J. Levine MD FCCP FAST, Gabriel Loor MD FACC FCCP, Jonathan P. Singer MD, Patrick J. Smith PhD, Hakim Azfar Ali MDLung transplantation (LTx) remains the ultimate treatment for many patients with advanced lung disease. Although the age cutoffs for LTx have been debated due to variable outcomes, the number of LTx procedures performed on patients aged ≥ 65 years has significantly increased in recent decades, reflecting the realities of an aging demographic. This trend underscores the unique management challenges
-
Lung Quantitative Computed Tomography Textures are Associated with Systemic Inflammation and Mortality in COPD. Chest (IF 9.5) Pub Date : 2025-04-22
Hira A Awan,Muhammad F A Chaudhary,Anthony D El-Sokkary,Eric A Hoffman,Alejandro P Comellas,Junfeng Guo,Igor Z Barjaktarevic,R Graham Barr,Surya P Bhatt,Sandeep Bodduluri,Russell P Bowler,Luis G Vargas Buonfiglio,Christopher B Cooper,Ashraf Fawzy,Annette T Hastie,Wassim W Labaki,Fernando J Martinez,Martha G Menchaca,Wanda O'Neal,Robert Paine,Joyce D Schroeder,Prescott G Woodruff,Jeffrey L Curtis,JosephBACKGROUND Chronic obstructive pulmonary disease (COPD) is characterized by persistent inflammation that is responsible for remodeling the bronchovascular bundles, which may lead to poor quality of life. Quantitative computed tomography (QCT) textures of the lung can capture local disease patterns of inflammation and related respiratory morbidity. RESEARCH QUESTION Are bronchovascular bundle textures
-
Impact of COVID-19 on Pulmonary Critical Care Fellows In-Training Exam Performance: A National Study Chest (IF 9.5) Pub Date : 2025-04-21
Mahmoud Alwakeel MD, Paru Patrawalla MD, Brian Carlin MD, Doreen Adrizzo-Harris MD, John Mastronarde MD, Joyce Reitzner MBA, Hiram L. Rivas Perez MD, XiaoFeng Wang PhD, Neal Chaisson MDBetween 2020 and 2022, the COVID-19 pandemic disrupted health and education. Many training institutions modified trainees’ rotations, decreasing outpatient clinics while increasing inpatient and ICU time. Understanding the pandemic’s impact on medical trainees’ cognitive performance is essential for informing strategies and supporting trainee well-being during crises.
-
Exercise Hemodynamics and the Evolving Definition of Precapillary Pulmonary Hypertension Chest (IF 9.5) Pub Date : 2025-04-21
Louisa A. Mounsey, Ceanna J. Kalaria, Alyssa Kowal, Casey Hoenstine, Shania McGinnis, Isabela Landsteiner, Rajeev Malhotra, Greg D. Lewis, Alexandra K. Wong, Alison S. Witkin, Josanna Rodriguez-Lopez, C. Corey Hardin -
XALOC-1: Clinical Remission Over 2 Years With Benralizumab in Severe Eosinophilic Asthma Chest (IF 9.5) Pub Date : 2025-04-19
Girolamo Pelaia MD, David J. Jackson FRCP PhD, Parameswaran Nair MD, Benjamin Emmanuel PhD, Trung N. Tran MD, Andrew Menzies-Gow PhD FRCP, Michael Watt PhD, Sheena Kayaniyil PhD, Silvia Boarino PhD, Javier Nuevo MBA, Marisa Pardal MPH, Anat Shavit DVM, Vivian H. Shih DrPH, David Cohen PhD, Claudia Loureiro PhD, Alicia Padilla-Galo MD PhDLong-term real-world data on clinical remission in patients with severe eosinophilic asthma (SEA) receiving biologics are lacking. We describe clinical remission over 2 years in patients with SEA receiving benralizumab.
-
Association of physical frailty with incidence and life expectancy of chronic obstructive pulmonary disease: a population-based cohort study. Chest (IF 9.5) Pub Date : 2025-04-19
Chao Liu,Hui Xiong,Xia Han,Yanling Lv,Decai Wang,Jiannan Hu,Ziling Li,Xinyue Ma,Yunfei Zhu,Shuyun Xu,Liangkai ChenBACKGROUND The bidirectional relationship between frailty and chronic obstructive pulmonary disease (COPD) is documented. However, longitudinal studies examining the combined effects of genetic predisposition and preserved ratio impaired spirometry (PRISm) on frailty in COPD development are lacking. RESEARCH QUESTION What is the association between physical frailty and the incidence and mortality of
-
Clinical Impact of Tirzepatide on Patients With OSA and Obesity Chest (IF 9.5) Pub Date : 2025-04-18
Jheng-Yan Wu, Chia-Chen Chen, Wan Ling Tu, Wan-Hsuan Hsu, Ting-Hui Liu, Ya-Wen Tsai, Po-Yu Huang, Min-Hsiang Chuang, Kuo-Chuan Hung, Tsung Yu, Chih-Cheng LaiOSA is a prevalent chronic condition linked to obesity that is associated with increased risks of cardiovascular and kidney disease. Although weight loss can improve OSA outcomes, additional effective therapeutic options are needed. Tirzepatide, a dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist, has shown promise in promoting significant weight loss and
-
Local Anesthetic Use in Pleural Procedures: Time to Reconsider the Guidelines? Chest (IF 9.5) Pub Date : 2025-04-18
Craig Mounsey MRCP, Imogen R. Mechie MRCP, Dinesh N. Addala MRCP, Rhea Suribhatla BM BCh, Zara O. Small BM BCh, Ella M. Smith BA, Robyn A.E. Gould BSc, Grace A. Annetts BA, Daniela Krouzkova BA, Nikolaos I. Kanellakis PhD, Najib M. Rahman DPhil -
Coronary Artery Calcification Identified on Lung Cancer Screening CT Scans: A Scoping Review. Chest (IF 9.5) Pub Date : 2025-04-18
Nada Al-Antary,Kelly A Hirko,Andrea E Cassidy-Bushrow,Katie R Zarins,Mike J Simoff,Thomas Song,Avi Cohen,Christine Neslund-DudasTOPIC IMPORTANCE Coronary artery calcification (CAC) can be a significant incidental finding on low-dose computed tomography (CT) scans performed for lung cancer screening (LCS). CAC presence and grade hold important diagnostic, and preventive value, particularly in patients without previously recognized coronary artery disease. This scoping review describes the prevalence of CAC as an incidental finding
-
Forecasting the Global Economic and Health Burden of COPD From 2025 Through 2050 Chest (IF 9.5) Pub Date : 2025-04-18
Elroy Boers PhD, Angier Allen MA, Meredith Barrett PhD, Adam V. Benjafield PhD, Mary B. Rice MD, Jadwiga A. Wedzicha MD, Leanne Kaye PhD, Heather J. Zar MD PhD, Sanjeev Sinha MD, Obianuju Ozoh MD, Laura E. Crotty Alexander MD, Atul Malhotra MDStudies have reported estimates of the economic and health burden of COPD. They have been limited largely to current-day estimates or relatively short-term future projections.
-
Characteristics, Prognosis, and European Society of Cardiology and European Respiratory Society Risk Stratification in Patients With Obesity and Pulmonary Arterial Hypertension Chest (IF 9.5) Pub Date : 2025-04-16
Giulio Savonitto MD, Davide Barbisan MD, Pietro Ameri MD PhD, Carlo Maria Lombardi MD, Mauro Driussi MD, Piero Gentile MD, Luke Howard DPhil FRCP, Matteo Toma MD, Matteo Pagnesi MD, Valentino Collini MD, Carolina Bauleo MD, Matteo Rugolotto MD, Giovanni Santi MD, Francesca Coppi MD, Gianluca Pagnoni MD, Pier Paolo Bocchino MD, Claudia Raineri MD, Alberto Giannoni MD, Massimo Imazio MD, Edoardo AiroThe impact of obesity on pulmonary arterial hypertension (PAH) remains largely underexplored, with excess weight potentially masking symptoms and affecting the reliability of current risk stratification tools.
-
Echocardiographic Parameters Enhance Risk Prediction Scores in Pulmonary Arterial Hypertension: Insights From the Redefining Pulmonary Hypertension through Pulmonary Vascular Disease Phenomics Network Chest (IF 9.5) Pub Date : 2025-04-12
Monica Mukherjee MD MPH, Vivek P. Jani MS, Ryan Osgueritchian MD, Hoda Mombeini MBBS, Aiden Abidov MD PhD, Gerald Beck PhD, Serpil Erzurum MD, Robert P. Frantz MD, Paul M. Hassoun MD, Anna R. Hemnes MD, Nicholas S. Hill MD, Evelyn M. Horn MD, Jiwon Kim MD, Deborah Kwon MD, A. Brett Larive MS, Peter J. Leary MD PhD, Jane A. Leopold MD, Stephen C. Mathai MD MHS, Reena Mehra MD, Margaret M. Park BS, ErikaEchocardiographic metrics of right ventricular (RV) chamber size and function enhance prognostication, risk stratification, and measurement of therapeutic response in patients with pulmonary arterial hypertension (PAH). The most effective metrics remain unclear, however.
-
Characterizing Sarcoidosis Patients With Obstructive Respiratory Physiology Chest (IF 9.5) Pub Date : 2025-04-11
Daniel VanDerhoef MD, Nicholas Marka MS, Benjamin Langworthy PhD, Nikhil Kapur BS, Bharat Thayagarajan MD PhD, David M. Perlman MD, Maneesh Bhargava MBBS PhDLung involvement occurs in > 95% of sarcoidosis cases. The World Association of Sarcoidosis and Other Granulomatous Disorders Organ Assessment Instrument does not assign the likelihood of lung involvement based on pulmonary function test (PFT) results. Clinical characteristics linked to normal and abnormal physiological pattern on PFTs in sarcoidosis are incompletely understood.
-
Machine Listening for OSA Diagnosis: A Bayesian Meta-Analysis Chest (IF 9.5) Pub Date : 2025-04-11
Benjamin Kye Jyn Tan MBBS (Hons) MRCS, Esther Yanxin Gao MBBS MRCS, Nicole Kye Wen Tan MBBS, Brian Sheng Yep Yeo, Claire Jing-Wen Tan MBBS (Hons) MRCS, Adele Chin Wei Ng MBBS MMed (ORL), Zhou Hao Leong MBBS MMed (ORL), Chu Qin Phua MBChB MMed (ORL) FRCS, Maythad Uataya MD Higher Grad. Dip. Clin. Sc. Dip. Thai Board (ORL & Sleep Medicine), Goh Liang Chye MBBS MRCS MSur (ORL-HNS), Thun How Ong MBBS MRCPAmong 1 billion patients worldwide with OSA, 90% remain undiagnosed. The main barrier to diagnosis is the overnight polysomnogram, which requires specialized equipment, skilled technicians, and inpatient beds available only in tertiary sleep centers. Recent advances in artificial intelligence (AI) have enabled OSA detection using breathing sound recordings.
-
-